Drug Detail:Flulaval quadrivalent (Influenza virus vaccine (injection) [ in-floo-en-za-vye-rus-vak-seen ])
Generic Name: INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215
Dosage Form: injectable suspension, for intramuscular use
Drug Class: Viral vaccines
For intramuscular injection only.
Dosage and Schedule
The dose and schedule for FLULAVAL QUADRIVALENT are presented in Table 1.
a One dose or 2 doses (0.5‑mL each) depending on vaccination history as per the annual Advisory Committee on Immunization Practices (ACIP) recommendation on prevention and control of seasonal influenza with vaccines. If 2 doses, administer each 0.5‑mL dose at least 4 weeks apart. | ||
Age |
Vaccination Status |
Dose and Schedule |
6 months through 8 years |
Not previously vaccinated with influenza vaccine |
Two doses (0.5‑mL each) at least 4 weeks apart |
Vaccinated with influenza vaccine in a previous season |
One or 2 dosesa (0.5‑mL each) |
|
9 years and older |
Not applicable |
One 0.5‑mL dose |
Administration Instructions
Shake well before administration. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. If either of these conditions exists, the vaccine should not be administered.
Attach a sterile needle to the prefilled syringe and administer intramuscularly.
The preferred sites for intramuscular injection are the anterolateral thigh for children aged 6 through 11 months and the deltoid muscle of the upper arm for persons aged 12 months and older. Do not inject in the gluteal area or areas where there may be a major nerve trunk.
Do not administer this product intravenously, intradermally, or subcutaneously.